Cardiac Manifestations of Graft-Versus-Host Disease

CancerCancer is the second most common cause of death globally. Hematological malignancyHematological malignancy is an important contributor to the global cancer burdenGlobal cancer burden and hematopoietic stem cell transplantationHematopoietic Stem Cell Transplantation (HSCT) (HSCT) is a curative therapeutic method in the advanced stages of such malignancies. HSCTHematopoietic Stem Cell Transplantation (HSCT) is associated with severe complications, such as graft versus host diseaseGraft Versus Host Disease (GVHD) (GVHD). The cardiovascular system is rarely reported as a target organ of GVHD, although this will affect survivor mortality and morbidity. The prevention, early diagnosis and adequate treatment of cardiovascular GVHD areGraft Versus Host Disease (GVHD) important in post-HSCT patients.